Literature DB >> 18220300

Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment-naïve chronically infected patient.

Philippe Colson, Nabil Brouk, Frédérique Lembo, Paul Castellani, Catherine Tamalet, René Gérolami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18220300     DOI： 10.1002/hep.22122

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  9 in total

1.  Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping.

Authors:  Sophie Vallet; Sylvie Larrat; Syria Laperche; Hélène Le Guillou-Guillemette; Florence Legrand-Abravanel; Françoise Bouchardeau; Adeline Pivert; Cécile Henquell; Audrey Mirand; Elisabeth André-Garnier; Valérie Giordanengo; Gisèle Lagathu; Vincent Thibault; Caroline Scholtes; Evelyne Schvoerer; Catherine Gaudy-Graffin; Sarah Maylin; Pascale Trimoulet; Etienne Brochot; Sébastien Hantz; Joël Gozlan; Anne-Marie Roque-Afonso; Patrick Soussan; Jean-Christophe Plantier; Charlotte Charpentier; Stéphane Chevaliez; Philippe Colson; Vincent Mackiewicz; Lina Aguilera; Sylvain Rosec; Stéphanie Gouriou; Nelly Magnat; Françoise Lunel-Fabiani; Jacques Izopet; Patrice Morand; Christopher Payan; Jean-Michel Pawlotsky
Journal:  J Clin Microbiol       Date:  2013-02-20       Impact factor: 5.948

2.  Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan.

Authors:  Abbas Ali Husseini; Khwaja Mir Islam Saeed; Esra Yurdcu; A Mithat Bozdayı
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

3.  Temporal dynamics of a predominant protease inhibitor-resistance mutation in a treatment-naive, hepatitis C virus-infected individual.

Authors:  Arthur Y Kim; Joerg Timm; Brian E Nolan; Laura L Reyor; Katherine Kane; Andrew C Berical; Kimon C Zachary; Georg M Lauer; Thomas Kuntzen; Todd M Allen
Journal:  J Infect Dis       Date:  2009-03-01       Impact factor: 5.226

4.  Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing.

Authors:  Akihiro Nasu; Hiroyuki Marusawa; Yoshihide Ueda; Norihiro Nishijima; Ken Takahashi; Yukio Osaki; Yukitaka Yamashita; Tetsuro Inokuma; Takashi Tamada; Takeshi Fujiwara; Fumiaki Sato; Kazuharu Shimizu; Tsutomu Chiba
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

Review 5.  Virologic Tools for HCV Drug Resistance Testing.

Authors:  Slim Fourati; Jean-Michel Pawlotsky
Journal:  Viruses       Date:  2015-12-04       Impact factor: 5.048

6.  Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C.

Authors:  Tanya L Applegate; Silvana Gaudieri; Anne Plauzolles; Abha Chopra; Jason Grebely; Michaela Lucas; Margaret Hellard; Fabio Luciani; Gregory J Dore; Gail V Matthews
Journal:  Antivir Ther       Date:  2014-08-08

7.  Analysis of Naturally Occurring Resistant Mutations to Hepatitis C Virus NS3 Protease Inhibitors: A Preliminary Study in South of Iran.

Authors:  Mozhgan Afrasiabi; Seyed Younes Hosseini; Ramin Yaghobi; Mohammad-Reza Fattahi; Maryam Ardebili; Mahboobeh Khodadad
Journal:  Jundishapur J Microbiol       Date:  2015-10-29       Impact factor: 0.747

8.  Variability and resistance mutations in the hepatitis C virus NS3 protease in patients not treated with protease inhibitors.

Authors:  Luciana Bonome Zeminian; Juliana Lara Padovani; Sílvia Maria Corvino; Giovanni Faria Silva; Maria Inês de Moura Campos Pardini; Rejane Maria Tommasini Grotto
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-02       Impact factor: 2.743

9.  Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients.

Authors:  Thomas Kuntzen; Joerg Timm; Andrew Berical; Niall Lennon; Aaron M Berlin; Sarah K Young; Bongshin Lee; David Heckerman; Jonathan Carlson; Laura L Reyor; Marianna Kleyman; Cory M McMahon; Christopher Birch; Julian Schulze Zur Wiesch; Timothy Ledlie; Michael Koehrsen; Chinnappa Kodira; Andrew D Roberts; Georg M Lauer; Hugo R Rosen; Florian Bihl; Andreas Cerny; Ulrich Spengler; Zhimin Liu; Arthur Y Kim; Yanming Xing; Arne Schneidewind; Margaret A Madey; Jaquelyn F Fleckenstein; Vicki M Park; James E Galagan; Chad Nusbaum; Bruce D Walker; Gerond V Lake-Bakaar; Eric S Daar; Ira M Jacobson; Edward D Gomperts; Brian R Edlin; Sharyne M Donfield; Raymond T Chung; Andrew H Talal; Tony Marion; Bruce W Birren; Matthew R Henn; Todd M Allen
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.